Craig Bowron

Oct 19, 2024 | kevinmd.com | Emily Hagen |Daniel Song |Craig Bowron

Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes!In this episode, we delve into a fascinating yet often overlooked medical phenomenon—near-death experiences (NDEs)—with  John C. Hagan III, an ophthalmologist and expert on the subject.

Sep 30, 2024 | kevinmd.com | Emily Hagen |Daniel Song |Craig Bowron |Phindile Chowa

Imagine a medical syndrome so common that as many as one in five patients who nearly die in a medical setting experience it. Also, imagine that this syndrome has a profound, lifelong effect on both the patient and their family. Finally, imagine that if this syndrome is mishandled by the patient’s physician, it may have major adverse consequences for the patient and their loved ones. Sounds like something all physicians and medical personnel should be able to recognize and treat, doesn’t it?

Jul 31, 2024 | kevinmd.com | Deepak Gupta |Emily Hagen |Daniel Song |Craig Bowron

Privacy protection does not cease to exist at death, as privacy laws protect information until 50 years post-mortem. So, why does the protected information of public figures often find its way into the public domain long before this embargoed period elapses, sometimes almost immediately after death? Firstly, the primary question is: What defines a public figure?

Jun 27, 2024 | mcpress.mayoclinic.org | Craig Bowron

A parade of witty and whimsical TV ads for Inspire — a Food and Drug Administration (FDA)-approved, surgically implanted device to treat sleep apnea — do a better job of explaining what Inspire isn’t, rather than what it is. As the manufacturer’s slogan — No mask. No hose. Just sleep — emphatically points out, Inspire is not a CPAP mask with attached hose.

Apr 11, 2024 | mcpress.mayoclinic.org | Craig Bowron

You can add Nov. 16, 2023, to July 16, 1945 — the day nuclear power moved from the theoretical to the actual — as an entry to the list of consequential moments for everyone’s favorite vertebrate, Homo sapiens. The news was easy to miss, but there it was. The United Kingdom announced that it would be the first country in the world to approve the use of gene editing as a medical therapy, starting with two inherited types of anemia: beta-thalassemia, and the more widely known sickle cell anemia.